| Literature DB >> 31043572 |
Xiaowei Li1,2,3, Brian Cho4, Russell Martin1,2,3, Michelle Seu4, Chi Zhang1,2,3, Zhengbing Zhou1,2,3, Ji Suk Choi1,2,3, Xuesong Jiang1,2,3, Long Chen1,2,3, Gurjot Walia4, Jerry Yan5, Megan Callanan5, Huanhuan Liu1,2,3, Kevin Colbert1,2, Justin Morrissette-McAlmon1,5, Warren Grayson1,2,5, Sashank Reddy6, Justin M Sacks6, Hai-Quan Mao7,2,3,5.
Abstract
Soft tissue losses from tumor removal, trauma, aging, and congenital malformation affect millions of people each year. Existing options for soft tissue restoration have several drawbacks: Surgical options such as the use of autologous tissue flaps lead to donor site defects, prosthetic implants are prone to foreign body response leading to fibrosis, and fat grafting and dermal fillers are limited to small-volume defects and only provide transient volume restoration. In addition, large-volume fat grafting and other tissue-engineering attempts are hampered by poor vascular ingrowth. Currently, there are no off-the-shelf materials that can fill the volume lost in soft tissue defects while promoting early angiogenesis. Here, we report a nanofiber-hydrogel composite that addresses these issues. By incorporating interfacial bonding between electrospun poly(ε-caprolactone) fibers and a hyaluronic acid hydrogel network, we generated a composite that mimics the microarchitecture and mechanical properties of soft tissue extracellular matrix. Upon subcutaneous injection in a rat model, this composite permitted infiltration of host macrophages and conditioned them into the pro-regenerative phenotype. By secreting pro-angiogenic cytokines and growth factors, these polarized macrophages enabled gradual remodeling and replacement of the composite with vascularized soft tissue. Such host cell infiltration and angiogenesis were also observed in a rabbit model for repairing a soft tissue defect filled with the composite. This injectable nanofiber-hydrogel composite augments native tissue regenerative responses, thus enabling durable soft tissue restoration outcomes.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31043572 DOI: 10.1126/scitranslmed.aau6210
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956